B.M.-Prem Medicare And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-07-2024
- Paid Up Capital ₹ 0.10 M
as on 16-07-2024
- Company Age 11 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.01 M
as on 16-07-2024
- Revenue -44.33%
(FY 2023)
- Profit -7.62%
(FY 2023)
- Ebitda -14.18%
(FY 2023)
- Net Worth 78.09%
(FY 2023)
- Total Assets -42.27%
(FY 2023)
About B.M.-Prem Medicare And Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.01 M.
Amit Agarwal, Ashish Agarwal, and Alok Agrawal serve as directors at the Company.
- CIN/LLPIN
U24100UP2014PTC061822
- Company No.
061822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2014
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at B.M.-Prem Medicare And Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Agrawal  | Director | 07-Jan-2014 | Current |
| Amit Agarwal | Director | 07-Jan-2014 | Current |
| Ashish Agarwal | Director | 07-Jan-2014 | Current |
Financial Performance of B.M.-Prem Medicare And Pharmaceuticals.
B.M.-Prem Medicare And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.33% decrease. The company also saw a slight decrease in profitability, with a 7.62% decrease in profit. The company's net worth Soared by an impressive increase of 78.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B.M.-Prem Medicare And Pharmaceuticals?
In 2023, B.M.-Prem Medicare And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medizone Drug Distributor Private LimitedActive 8 months 29 daysAmit Agarwal and Alok Agrawal are mutual person
- Acr Real Estate Private LimitedActive 10 years 1 month
Amit Agarwal and Alok Agrawal are mutual person
- B M Infradevelopers Private LimitedActive 14 years 7 months
Amit Agarwal, Ashish Agarwal and 1 more are mutual person
- B. M. Medical And Research Centre Private LimitedActive 19 years 1 month
Amit Agarwal, Ashish Agarwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Dec 2021 | ₹2.01 M | Open |
How Many Employees Work at B.M.-Prem Medicare And Pharmaceuticals?
Unlock and access historical data on people associated with B.M.-Prem Medicare And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B.M.-Prem Medicare And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B.M.-Prem Medicare And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
